You have 9 free searches left this month | for more free features.

Refractory Germ Cell Tumors

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Germ Cell Tumor, Seminoma, Non-seminomatous Germ Cell Tumor Trial in Indianapolis (Cabozantinib)

Recruiting
  • Germ Cell Tumor
  • +3 more
  • Indianapolis, Indiana
    Indiana University Melvin & Bren Simon Cancer Center
Nov 16, 2022

Germ Cell Tumor, Nonseminomatous Germ Cell Tumor, Seminoma Trial in United States (Durvalumab, Tremelimumab)

Active, not recruiting
  • Germ Cell Tumor
  • +5 more
  • Basking Ridge, New Jersey
  • +6 more
May 2, 2022

Incurable Platinum Refractory Germ Cell Tumors, Tumors Trial in Indianapolis, New York, Philadelphia (ASP1650)

Completed
  • Incurable Platinum Refractory Germ Cell Tumors
  • Tumors
  • Indianapolis, Indiana
  • +2 more
Nov 30, 2021

CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)

Active, not recruiting
  • Central Nervous System Tumor, Pediatric
  • +8 more
  • EGFR806-specific chimeric antigen receptor (CAR) T cell
  • Seattle, Washington
    Seattle Children's Hospital
Jan 18, 2023

CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)

Recruiting
  • Central Nervous System Tumor, Pediatric
  • +8 more
  • HER2-specific chimeric antigen receptor (CAR) T cell
  • Seattle, Washington
    Seattle Children's Hospital
Dec 14, 2022

Germ Cell Tumors, Measurable Disease Trial in Milano (Pazopanib)

Completed
  • Germ Cell Tumors
  • Measurable Disease
  • Milano, Mi, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
May 12, 2021

Germ Cell Tumor Trial in Milano (Durvalumab, Tremelimumab)

Terminated
  • Germ Cell Tumor
  • Milano, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
May 12, 2021

Non-CNS Germ Cell Tumors (Seminomas and Nonseminomas) Trial in France, United Kingdom, United States (Tivantinib (ARQ 197))

Terminated
  • Non-CNS Germ Cell Tumors (Seminomas and Nonseminomas)
  • Tivantinib (ARQ 197)
  • Los Angeles, California
  • +9 more
Mar 12, 2021

Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Canada, United States (Onivyde, Talazoparib,

Recruiting
  • Recurrent Solid Tumor
  • +21 more
  • Palo Alto, California
  • +8 more
Jun 7, 2022

Ex Vivo Drug Sensitivity Testing and Mutation Profiling

Completed
  • Recurrent Childhood Acute Myeloid Leukemia
  • +13 more
    • Miami, Florida
      Nicklaus Children's Hospital
    Jan 18, 2023

    Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Valhalla (Vorinostat)

    Recruiting
    • Ewing Sarcoma
    • +5 more
    • Valhalla, New York
      New York Medical College
    Oct 24, 2022

    CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

    Recruiting
    • Central Nervous System Tumor
    • +10 more
    • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
    • Seattle, Washington
      Seattle Children's Hospital
    Dec 14, 2022

    Pediatric Cancer, Solid Tumors, Rhabdomyosarcoma Trial in Washington (Magnetic resonance high intensity focused ultrasound,

    Recruiting
    • Pediatric Cancer
    • +9 more
    • Magnetic resonance high intensity focused ultrasound
    • Lyso-thermosensitive liposomal doxorubicin
    • Washington, District of Columbia
      Children's National Medical Center
    Dec 10, 2021

    Relapsed Pediatric Solid Tumors, Refractory Pediatric Solid Tumors, Rhabdomyosarcoma Trial in Washington, Cincinnati (Magnetic

    Active, not recruiting
    • Relapsed Pediatric Solid Tumors
    • +9 more
    • Magnetic Resonance High Intensity Focused Ultrasound
    • Washington, District of Columbia
    • +1 more
    Jan 21, 2022

    Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

    Recruiting
    • Pediatric Solid Tumor
    • +15 more
    • second generation 4-1BBζ EGFR806-EGFRt
    • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
    • Seattle, Washington
      Seattle Children's Hospital
    May 2, 2022

    Germ Cell Tumors Trial in France (Paclitaxel, Ifosfamide, Carboplatine)

    Completed
    • Germ Cell Tumors
    • Angers, France
    • +11 more
    Jan 11, 2021

    Germ Cell Tumor, Testis Cancer, Testicular Cancer Trial in Indianapolis (Guadecitabine (SGI-110))

    Completed
    • Germ Cell Tumor
    • +2 more
    • Guadecitabine (SGI-110)
    • Indianapolis, Indiana
    • +1 more
    Sep 22, 2020

    Solid Tumors, Soft Tissue Sarcoma, Ewing Sarcoma Trial (Magnetic Resonance-Guided High Intensity Focused Ultrasound,

    Not yet recruiting
    • Solid Tumors
    • +8 more
    • Magnetic Resonance-Guided High Intensity Focused Ultrasound
    • Lyso-thermosensitive Liposomal Doxorubicin
    • (no location specified)
    Mar 10, 2022

    Germ Cell Tumors of the Central Nervous System

    Recruiting
    • Germ Cell Tumor of CNS
      • Beijing, China
        Sanbo Brain Hospital Capital Medical University
      Apr 19, 2023

      Germ Cell Tumor Trial (Thromboprophylaxis)

      Not yet recruiting
      • Germ Cell Tumor
      • (no location specified)
      May 16, 2023

      Malignant Ovarian Germ Cell Tumors

      Recruiting
      • Fertility Issues
      • observational study
      • Cairo, Egypt
        Department of Obstetrics & Gynecology
      Jun 7, 2023

      Testicular Germ Cell Tumor Trial in Saint-Petersburg (Orchofuniculectomy with simultaneous laparoscopic biopsy of the sentinel

      Recruiting
      • Testicular Germ Cell Tumor
      • Orchofuniculectomy with simultaneous laparoscopic biopsy of the sentinel lymph node using indocyanine green dye with/without methylene blue dye.
      • Radiopharmaceutical administration (Technetium/methylene blue)
      • Saint-Petersburg, Russian Federation
        Federal State Budgetary Institute N.N. Petrov National Medical R
      Nov 10, 2023

      MiRNA in Detecting Active Germ Cell Tumors in Early Suspected

      Recruiting
      • Malignant Testicular Germ Cell Tumor
      • Non-Interventional Study
      • Los Angeles, California
      • +1 more
      Sep 28, 2023